| stavudine / Generic mfg. |
NCT00002308: A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs |
|
|
| Completed | N/A | | US | Stavudine | Bristol-Myers Squibb | HIV Infections | | 11/91 | | |
NCT00002307: A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients |
|
|
| Completed | N/A | | US | Stavudine, Zidovudine | Bristol-Myers Squibb | HIV Infections | | 12/94 | | |
NCT00002349: A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection. |
|
|
| Completed | N/A | 40 | US | Stavudine | Bristol-Myers Squibb | HIV Infections | 05/99 | 05/99 | | |
NCT00002176: A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection |
|
|
| Completed | N/A | | US | Hydroxyurea, Nelfinavir mesylate, Stavudine, Didanosine | Bristol-Myers Squibb | HIV Infections | 03/00 | 03/00 | | |
NCT00002177: A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection |
|
|
| Completed | N/A | | US | Hydroxyurea, Nelfinavir mesylate, Stavudine, Didanosine | Bristol-Myers Squibb | HIV Infections | 03/00 | 03/00 | | |
NCT00002207: A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients |
|
|
| Completed | N/A | | US | Stavudine, Didanosine | Bristol-Myers Squibb | HIV Infections | 02/04 | 02/04 | | |
NCT00002168: A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients |
|
|
| Completed | N/A | 200 | US | Indinavir sulfate, Lamivudine, Stavudine, Zidovudine, Didanosine | Bristol-Myers Squibb | HIV Infections | | | | |
NCT00002369: A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs |
|
|
| Completed | N/A | 200 | US | Indinavir sulfate, Lamivudine, Stavudine, Zidovudine | Bristol-Myers Squibb | HIV Infections | | | | |
NCT00255840: Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities |
|
|
| Completed | N/A | 812 | US | Monitoring by an HIV-trained medical doctor, Monitoring by an HIV-trained primary care nurse, Efavirenz, EFV, Lamivudine, 3TC, Lopinavir/Ritonavir, LPV/RTV, Nevirapine, NVP, Stavudine, d4T | CIPRA SA, National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections | 01/09 | 01/09 | | |
NCT00100646: Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa |
|
|
| Completed | N/A | 30 | RoW | Structured treatment interruption, STI, Lamivudine, Lopinavir/Ritonavir, Stavudine, Rabies de novo antigen | The Wistar Institute | HIV Infections | 03/10 | 03/10 | | |
NCT00021632: Effects of Ribavirin on Zidovudine or Stavudine |
|
|
| Completed | N/A | 32 | US | | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections, Hepatitis C | | | | |
